Michael P. Bailey

President, Chief Executive Officer & Director at AVEO Pharmaceuticals Inc.

Michael P. Bailey

Michael P. Bailey

President, Chief Executive Officer & Director at AVEO Pharmaceuticals Inc.

Overview
Career Highlights

AVEO Pharmaceuticals Inc.

RelSci Relationships

916

Number of Boards

1

Birthday

1966

Age

54

Relationships
RelSci Relationships are individuals Michael P. Bailey likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President & Chief Executive Officer at NitroMed, Inc.

Relationship likelihood: Strong

Former Partner at Venrock Associates

Relationship likelihood: Strong

Founder at RCY Medicine

Relationship likelihood: Strong

Executive Chairman at Kew, Inc.

Relationship likelihood: Strong

Vice President, Finance & Administration & Chief Financial Officer at Sanofi Pasteur Biologics LLC

Relationship likelihood: Strong

Secretary, Senior Vice President & General Counsel at AVEO Pharmaceuticals Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Engage Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at AVEO Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Senior Vice President at Eli Lilly & Company

Relationship likelihood: Strong

Founder at Molquant

Relationship likelihood: Strong

Paths to Michael P. Bailey
Potential Connections via
Relationship Science
You
Michael P. Bailey
President, Chief Executive Officer & Director at AVEO Pharmaceuticals Inc.
Education
B.S. in Psychology

St. Lawrence University was founded in 1856 as a coeducational institution and remains the oldest continuously coeducational college in New York State. The mission of St. Lawrence University is to provide an inspiring and demanding undergraduate education in the liberal arts to students selected for their seriousness of purpose and intellectual promise.

MBA International Marketing

The Mendoza College of Business is a comprehensive full-time business school at the University of Notre Dame in Notre Dame, Indiana, United States. It offers six majors in the undergraduate program and four graduate degrees—MBA, EMBA, accountancy and non-profit management.

Career History
Head, Worldwide Commercial Organization
1999 - 2008

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company has utilized the many advances made in the fields of molecular biology, oncology, genomics, and antibody engineering to build a pipeline of product candidates designed to address specific genetic mechanisms involved in cancer growth and development. The company was founded in 1984 and is headquartered in New York, NY.

Chief Commercial Officer & Senior Vice President-Business Development
2008 - 2010

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.

President, Chief Executive Officer & Director
2010 - Current

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Boards & Committees
Member, Board of Directors
2015 - Current

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Transactions
Details Hidden

AVEO Pharmaceuticals Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael P. Bailey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael P. Bailey's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael P. Bailey.